Development of vaccines for Chagas disease (CRUZIVAX): stakeholders' preferences and potential impacts on healthcare

• Autores principales: Francesco Ramponi (Autor), Céline Aerts (Autor), Paula Sartor (Autor), María Jesús Pinazo (Autor), Héctor Freilij (Autor), Carlos A. Guzmán (Autor), Emilio Malchiodi (Autor), Elisa Sicuri (Autor)
• Formato: Libro
• Publicado: Elsevier, 2023-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

A vaccine for Chagas disease does not currently exist. This study aims to inform the development of two vaccines for the prevention and treatment of Trypanosoma cruzi infection, and guide their pre-clinical phase up to clinical phase I. The three main objectives are: 1) to explore patients' and...